Keyword search

Filter results by

Search Help
Currently selected filters that can be removed

Keyword(s)

Type

1 facets displayed. 0 facets selected.

Year of publication

3 facets displayed. 0 facets selected.

Geography

1 facets displayed. 0 facets selected.

Survey or statistical program

1 facets displayed. 1 facets selected.
Sort Help
entries

Results

All (3)

All (3) ((3 results))

  • Articles and reports: 88-003-X20050028021
    Geography: Canada
    Description:

    Between 1997 and 2003, the number of innovative biotechnology firms rose from 282 to 490. Biotechnology in Canada continued to expand between 2001 and 2003, generating revenues of almost $4 billion. Biotechnology companies have more than quadrupled their revenues since 1997, making biotechnology a fast growing activity.

    Release date: 2005-06-20

  • Articles and reports: 88-001-X20010047917
    Description:

    Biotechnology is an enabling technology - one that has been compared to electricity or microelectronics - because it has the potential to transform production processes, products and services in a wide range of sectors of the economy. At present, major applications of biotechnology are taking place in health, agriculture and agrifood, and natural resources (e.g. forestry and mining). This survey is intended to quantify the level of industrial activity in biotechnology research and development by sector of application and to reveal trends in spending.

    Release date: 2001-05-18

  • Articles and reports: 88-001-X20000027928
    Description:

    The statistics presented in this bulletin are derived from our latest survey of research and development activities in Canadian industry. In 1997, a decision was made to reduce response burden by eliminating the short survey forms in favour of using administrative data. Biotechnology data are not currently available from administrative data. Therefore, only those research and development performers with over one million dollars of intramural research and development expenditures are included in these statistics. Based on 1995, the last year of full coverage, 87.6% of biotechnology research and development expenditures were made by these large performers, which represented 24% of all companies reporting biotechnology research and development activities.

    Release date: 2000-06-16
Data (0)

Data (0) (0 results)

No content available at this time.

Analysis (3)

Analysis (3) ((3 results))

  • Articles and reports: 88-003-X20050028021
    Geography: Canada
    Description:

    Between 1997 and 2003, the number of innovative biotechnology firms rose from 282 to 490. Biotechnology in Canada continued to expand between 2001 and 2003, generating revenues of almost $4 billion. Biotechnology companies have more than quadrupled their revenues since 1997, making biotechnology a fast growing activity.

    Release date: 2005-06-20

  • Articles and reports: 88-001-X20010047917
    Description:

    Biotechnology is an enabling technology - one that has been compared to electricity or microelectronics - because it has the potential to transform production processes, products and services in a wide range of sectors of the economy. At present, major applications of biotechnology are taking place in health, agriculture and agrifood, and natural resources (e.g. forestry and mining). This survey is intended to quantify the level of industrial activity in biotechnology research and development by sector of application and to reveal trends in spending.

    Release date: 2001-05-18

  • Articles and reports: 88-001-X20000027928
    Description:

    The statistics presented in this bulletin are derived from our latest survey of research and development activities in Canadian industry. In 1997, a decision was made to reduce response burden by eliminating the short survey forms in favour of using administrative data. Biotechnology data are not currently available from administrative data. Therefore, only those research and development performers with over one million dollars of intramural research and development expenditures are included in these statistics. Based on 1995, the last year of full coverage, 87.6% of biotechnology research and development expenditures were made by these large performers, which represented 24% of all companies reporting biotechnology research and development activities.

    Release date: 2000-06-16
Reference (0)

Reference (0) (0 results)

No content available at this time.

Date modified: